EUROFINS SCIENT Gross Profit 2018-2024 | ERFSF
EUROFINS SCIENT annual/quarterly gross profit history and growth rate from 2018 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- EUROFINS SCIENT gross profit for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
- EUROFINS SCIENT gross profit for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
- EUROFINS SCIENT annual gross profit for 2024 was $1.558B, a 16.59% increase from 2023.
- EUROFINS SCIENT annual gross profit for 2023 was $1.336B, a 10.39% decline from 2022.
- EUROFINS SCIENT annual gross profit for 2022 was $1.491B, a 31.51% decline from 2021.
| EUROFINS SCIENT Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $1,558 |
| 2023 | $1,336 |
| 2022 | $1,491 |
| 2021 | $2,177 |
| 2020 | $1,543 |
| 2019 | $933 |
| 2018 | $769 |
| 2017 | $580 |
| 2016 | $2,762 |
| 2015 | $0 |
| EUROFINS SCIENT Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2024-12-31 | |
| 2024-06-30 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2019-06-30 | |
| 2018-12-31 | |
| 2018-06-30 | |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $14.562B | $7.522B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.177B | 26.18 |
| CVS Health (CVS) | United States | $78.558B | 9.80 |
| Elevance Health (ELV) | United States | $63.743B | 8.57 |
| Cencora (COR) | United States | $55.449B | 19.29 |
| DiDi Global (DIDIY) | China | $23.674B | 25.15 |
| Labcorp Holdings (LH) | United States | $21.769B | 17.18 |
| Natera (NTRA) | United States | $18.251B | 0.00 |
| BioMerieux (BMXMF) | France | $17.068B | 0.00 |
| ICON (ICLR) | Ireland | $13.663B | 13.15 |
| CochLear (CHEOY) | Australia | $13.429B | 0.00 |
| Solventum (SOLV) | United States | $12.346B | 13.07 |
| Medpace Holdings (MEDP) | United States | $12.001B | 31.76 |
| Revvity (RVTY) | United States | $10.361B | 17.98 |
| Viatris (VTRS) | United States | $10.258B | 3.52 |
| Avantor (AVTR) | United States | $9.158B | 13.31 |
| Sonic Healthcare (SKHHY) | Australia | $8.783B | 0.00 |
| HealthEquity (HQY) | United States | $8.388B | 36.74 |
| Charles River Laboratories (CRL) | United States | $8.332B | 16.33 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.144B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $4.822B | 32.45 |
| Amplifon S.p.A (AMFPF) | Italy | $3.915B | 21.43 |
| BrightSpring Health Services (BTSG) | United States | $3.630B | 33.31 |
| Sotera Health (SHC) | United States | $3.262B | 18.53 |
| GeneDx Holdings (WGS) | United States | $2.909B | 67.07 |
| Surgery Partners (SGRY) | United States | $2.813B | 36.58 |
| Alignment Healthcare (ALHC) | United States | $2.729B | 0.00 |
| Concentras Parent (CON) | United States | $2.560B | 14.79 |
| Organon (OGN) | United States | $2.522B | 2.68 |
| Progyny (PGNY) | United States | $2.015B | 44.36 |
| Premier (PINC) | United States | $1.769B | 13.43 |
| GoodRx Holdings (GDRX) | United States | $1.711B | 34.21 |
| PACS (PACS) | United States | $1.686B | 0.00 |
| Ardent Health (ARDT) | United States | $1.516B | 6.46 |
| Teladoc Health (TDOC) | United States | $1.274B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.213B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.052B | 8.01 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
| Agilon Health (AGL) | United States | $0.741B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.702B | 6.57 |
| CareDx (CDNA) | United States | $0.684B | 10.68 |
| Embecta (EMBC) | United States | $0.594B | 4.00 |
| LifeMD (LFMD) | United States | $0.473B | 0.00 |
| Nutex Health (NUTX) | United States | $0.471B | 7.13 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 10.48 |
| Sonida Senior Living (SNDA) | United States | $0.461B | 0.00 |
| So-Young (SY) | China | $0.451B | 0.00 |
| Omada Health (OMDA) | $0.451B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.449B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.448B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.407B | 0.00 |
| Enhabit (EHAB) | United States | $0.340B | 28.00 |
| Oncology Institute (TOI) | United States | $0.327B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.278B | 0.00 |
| Beauty Health (SKIN) | United States | $0.194B | 0.00 |
| DocGo (DCGO) | United States | $0.139B | 22.67 |
| Sera Prognostics (SERA) | United States | $0.105B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.078B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| KindlyMD (NAKA) | United States | $0.053B | 0.00 |
| Biodesix (BDSX) | United States | $0.052B | 0.00 |
| ModivCare (MODV) | United States | $0.041B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |